facebook page
Follow Me on Pinterest
twitter page
google plus page
rss feed

Recalled Product

Item detail and remedy information

Search Recalls or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Home > Recalled Products > Medical Devices > Defect > Alaris Alaris Pump Module Model 8100 And Certain Alaris Pump Infusion Sets

Recall: Alaris Alaris Pump Module Model 8100 And Certain Alaris Pump Infusion Sets


On 2019-07-18, the FDA announced that BD is conducting a recall on Alaris Pump Module Model 8100 And Certain Alaris Pump Infusion Sets due to a possible . The recalled products were sold under the brand name(s) Alaris during an unspecified time period throughout the regions shown in the map below.

In recent months, there have been 5 medical devices recalls due to potential defect, including endotracheal tubes, infant warmers ge healthcare's giraffe and panda i-res infant warmers and more. Additionally, there have been 1 drug and medical device recalls due to other health hazards as well as 49 food recalls.

Email Me About Recalls On:
Food  |  Drugs  |  Medical Devices  |  Pet Care Products  |  All of These

FDA Recall
Note: Images may not be available for every version. Please review the detailed description below.

Company Contact Information:

Name: BD
Phone: 888-562-6018

Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.

Detailed Recall Information

Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.

Product Description: Alaris Pump Module Model 8100 and Certain Alaris Pump Infusion Sets

Brand Name(s): Alaris

Reason for Recall: Defect

Official Recall Date: 2019-07-18

Note: Although this recall announcement is dated 07/18/2019, it was not published by the FDA until 07/22/2019.


Additional information provided by the

Read Announcement

  • Share
  • Tweet
  • Email
  • BD Provides Update on Voluntary Recalls of Alaris(TM) Pump Module Model 8100 and Certain Alaris(TM) Pump Infusion Sets Summary Company Announcement Date: July 18, 2019 FDA Publish Date: July 18, 2019 Product Type: Medical Devices Reason for Announcement: Recall Reason Description Weakening of the plastic can lead to damage or separation of the bezel posts which can cause issues with infusion, or unintended delivery of medication when pump module is not in running status Company Name: BD Brand Name: Brand Name(s) Alaris Product Description: Product Description Alaris Pump Module Model 8100 and Certain Alaris Pump Infusion Sets Company Announcement

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls related to certain Alaris(TM) Pump Modules Model 8100 manufactured between April 2011 and June 2017 and certain model codes and lot numbers of the Alaris(TM) Pump Infusion Sets used with the Alaris(TM) Pump Model 8100. BD has already notified customers affected by these recalls. Both products were formerly marketed under the CareFusion brand, which BD acquired in March 2015.

    Both actions have been designated as a Class I recall by the U.S. Food and Drug Administration (FDA). Both recalls have been associated with medical device reporting (MDR) submissions, several of which are associated with serious injuries.

    Alaris(TM) Pump Module Model 8100

    In a recall notification sent on April 15, 2019, BD informed clinicians that the bezel assemblies in the Alaris pump modules subject to this recall expansion were manufactured with a specific type of plastic material. The company conducted an investigation and determined that the bezel manufacturing process resulted in weakened plastic. Over time, further weakening of the plastic has the potential to lead to separation of the bezel posts, as well as other damage to the bezel, which may result in free-flow, over-infusion, under-infusion or interruption of infusion.

    No products manufactured after June 2017 are affected by this recall, including the BD Alaris(TM) PCU and BD Alaris(TM) Pump Module that were introduced in March 2018.

    BD is contacting the customers affected by the Alaris Pump Module Model 8100 bezel recall to schedule replacement of bezel assemblies. On April 15, 2019, the BD customer notification instructed customers to inspect all pumps included in this action during the annual preventive maintenance, and if damage is found, the pump should be removed from service and BD should be contacted. The revised recall notification indicates that until the bezels affected by this recall are replaced, customers should inspect both Priority 1 and Priority 2 pumps as soon as feasible. In addition to posting the updated recall notification on BD's website, this updated notification will be sent to all customers by July 31, 2019.

    There are no changes to the affected product list. Customers should continue to refer to the attachments included in the recall notification issued on April 15, 2019.

    Information about this recall, including the original and updated recall notification, is available on BD's website at or call BD at 888-562-6018.

    Alaris(TM) Infusion Sets

    In a recall notification sent on May 6, 2019, BD confirmed that an incomplete occlusion can occur on the pumping segment of certain Alaris(TM) Pump Model 8100 infusion sets. This is caused by a variation in the wall thickness of the pumping segment of the affected infusion sets. Use of the affected products has the potential to lead to unintended delivery of medication when the pump module is not in running status, flow inaccuracies through the pumping cycle process resulting in an over-infusion, and the potential for serious patient injury depending on the type of medication that is being delivered. Instructions for customers, including a full list of affected product codes, lot numbers and expiration dates are included on the BD website at BD is instructing customers to destroy all Alaris Infusion Sets affected by this recall.

    Customer inquiries related to this action should be addressed to BD's Regional Customer Quality team at 888-237-2762.

    FDA MedWatch Reporting

    Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

    • Complete and submit the report Online
    • Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

    • # # #
      About BD

      BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit

      Company Contact Information Consumers: 888-562-6018 Media: Kristen Cardillo, BD Public Relations 201.847.5657
      • Content current as of:


      • Regulated Product(s)

Latest Safety Recalls

Select image for details, including additional styles.




Do you have comments or questions about this recall? Share them here.
Note: The recalling companies may not be monitoring these comments; they should be directed toward the public. Community Guidelines apply.
comments powered by Disqus
Back to Top

Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.

Search Recalled Products or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Latest Product Recalls
Register Products
Check for Recalls
Find Resources
Brands & Retailers
Connect to Customers

Consignment Sales
Check Inventory
Install Recall Finder
Take Safety Pledge

Home Inspectors
Check Appliances
APIs & Feeds
Recall Search for Web
Recall Search for Mobile
Facebook Apps

Product Recall Statistics